Pharma Major #Glenmark Pharmaceuticals Ltd on Tuesday Said It Has Received Final Approval ... - Latest Tweet by IANS India

Pharma major #Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval by the United States Food & Drug Administration (@US_FDA) for Clindamycin Phosphate Foam, 1 per cent, the generic version of Evoclin Foam, 1 per cent, of Mylan Pharmaceuticals Inc. pic.twitter.com/oleoTRB6U0— IANS Tweets (@ians_india) September 21, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)